Table 1

Characteristics of asymptomatic individuals with SARS-CoV-2 infection and symptomatic patients with COVID-19*

Asymptomatic individuals (n=39)Symptomatic patients (n=144)P value
Age, median (IQR), y25.0 (21.5–34.0)26.5 (22.0–46.0)0.22
Male sex, n (%)22 (56)62 (43)0.14
Underlying diseases, n (%)3 (8)26 (18)0.12
 Hypertension05
 Asthma04
 Liver disease02
 COPD01
 Solid cancer01
 Rheumatologic disease10
 Other2†13‡
Interval from the first swab for diagnosis to the start of isolation, median (IQR), days6.0 (4.5–7.0)6.0 (4.0–9.0)0.84
Interval from initial confirmation to follow-up RT-PCR testing, median (IQR), days12 (9–14)13 (11–15)0.06
Interval from symptom onset to follow-up RT-PCR testing, median (IQR), daysNA26±6NA
Positive result on follow-up RT-PCR testing, n (%)21 (54)92 (64)0.25
Ct values, mean±SD
E gene31.15±2.7231.43±2.80>0.99
RdRp gene32.26±2.8632.93±2.870.92
N gene33.05±2.5233.28±2.48>0.99
  • *Categorical variables were compared using the Fisher’s exact test or χ2 test, as appropriate, and continuous variables were compared using the Mann-Whitney U test or Student’s t-test. All tests of significance were two-tailed.

  • †Includes thyroid disease (n=1) and allergic rhinitis (n=1).

  • ‡Includes allergic rhinitis (n=8), hyperlipidaemia (n=2), thyroid disease (n=2) and nephrotic syndrome (n=1).

  • Ct, cycle threshold; NA, not available; RT-PCR, reverse transcription-PCR.